new_0222_0506|IKNA|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0506|IKNA|1|Ikena Oncology Inc Total Current Assets (Quarterly) (USD)|Ikena Oncology Inc Cash and Short Term Investments (Quarterly) (USD)|Ikena Oncology Inc Inventories (Quarterly) (USD)|Ikena Oncology Inc Net PP&E (Quarterly) (USD)|Ikena Oncology Inc Goodwill and Intangibles (Quarterly) (USD)|Ikena Oncology Inc Total Liabilities (Quarterly) (USD)|Ikena Oncology Inc Total Current Liabilities (Quarterly) (USD)|Ikena Oncology Inc Total Long Term Liabilities (Quarterly) (USD)|Ikena Oncology Inc Total Deposits (Quarterly) (USD)|Ikena Oncology Inc Book Value (Quarterly) (USD)|Ikena Oncology Inc Retained Earnings (Quarterly) (USD)|Ikena Oncology Inc Treasury Stock (Quarterly) (USD)|Ikena Oncology Inc EV to Revenues|Ikena Oncology Inc EV to Earnings|Ikena Oncology Inc EV to Free Cash Flow|Ikena Oncology Inc EV to Assets (Quarterly)|Ikena Oncology Inc PS Ratio|Ikena Oncology Inc PE Ratio|Ikena Oncology Inc Price to Book Value|Ikena Oncology Inc PEG Ratio|Ikena Oncology Inc Debt to Equity Ratio|Ikena Oncology Inc Dividend Yield|Ikena Oncology Inc Shareholder Yield (TTM)|Ikena Oncology Inc Percent of Shares Outstanding Short|Ikena Oncology Inc Total Receivables (Quarterly) (USD)|Ikena Oncology Inc Total Payables (Quarterly) (USD)|Ikena Oncology Inc Total Capital Stock (Quarterly) (USD)|Ikena Oncology Inc Return on Invested Capital|Ikena Oncology Inc Quality Ratio Score|Ikena Oncology Inc Momentum Score|Ikena Oncology Inc Beta (1Y)|Ikena Oncology Inc Sustainable Growth Rate (TTM)|Ikena Oncology Inc Institutional Investor Ownership Percentage|Ikena Oncology Inc Average Diluted Shares Outstanding (Quarterly)|Ikena Oncology Inc Total Employees (Annual)|Ikena Oncology Inc EPS Diluted (Quarterly) (USD)|Ikena Oncology Inc SG&A Expense (Quarterly) (USD)|Ikena Oncology Inc Shares Outstanding|Ikena Oncology Inc Repurchase of Capital Stock (Quarterly) (USD)|Ikena Oncology Inc Ordinary Shares Number (Quarterly)|Ikena Oncology Inc Payout Ratio|Ikena Oncology Inc Quick Ratio (Quarterly)|Ikena Oncology Inc Normalized Diluted EPS (Quarterly) (USD)|Ikena Oncology Inc Stock Buybacks (Quarterly) (USD)|Ikena Oncology Inc Effective Tax Rate (TTM)|Ikena Oncology Inc Return on Equity|Ikena Oncology Inc Net Income (TTM) (USD)|Ikena Oncology Inc Revenue (TTM) (USD)|Ikena Oncology Inc Dividend Per Share (Quarterly) (USD)|Ikena Oncology Inc Revenue (Quarterly) (USD)|Ikena Oncology Inc Gross Profit (Quarterly) (USD)|Ikena Oncology Inc Pre-Tax Income (Quarterly) (USD)|Ikena Oncology Inc Net Income (Quarterly) (USD)|Ikena Oncology Inc Net Interest Income (Quarterly) (USD)|Ikena Oncology Inc Price (USD)|Ikena Oncology Inc Total Return Price (USD)|Ikena Oncology Inc Enterprise Value (USD)|Ikena Oncology Inc 30-Day Average Daily Volume|Ikena Oncology Inc 1 Year Price Returns (Daily)|Ikena Oncology Inc Short Interest|Ikena Oncology Inc PE Ratio (Forward)|Ikena Oncology Inc PE Ratio (Forward 1y)|Ikena Oncology Inc PS Ratio (Forward)|Ikena Oncology Inc PS Ratio (Forward 1y)|Ikena Oncology Inc Quarterly EPS Estimates (USD)|Ikena Oncology Inc Quarterly Revenue Estimates (USD)|Ikena Oncology Inc Quarterly EPS Surprise|Ikena Oncology Inc Quarterly Revenue Surprise|Ikena Oncology Inc Quarterly Actual EPS (USD)|Ikena Oncology Inc Quarterly Actual Revenue (USD)|Ikena Oncology Inc Revenue Estimates for Current Fiscal Year (USD)|Ikena Oncology Inc Revenue Estimates for Next Fiscal Year (USD)|Ikena Oncology Inc Price Target (USD)|Ikena Oncology Inc Consensus Recommendation|Ikena Oncology Inc Price Target Num Estimates|Ikena Oncology Inc EPS Estimates for Current Fiscal Year (USD)|Ikena Oncology Inc EPS Estimates for Next Fiscal Year (USD)|Ikena Oncology Inc Research and Development Expense (Quarterly) (USD)|Ikena Oncology Inc Reconciled Depreciation (Quarterly) (USD)|Ikena Oncology Inc Non-Operating Interest Expense (Quarterly) (USD)|Ikena Oncology Inc Land and Improvements (Quarterly) (USD)|Ikena Oncology Inc Buildings and Improvements (Quarterly) (USD)|Ikena Oncology Inc Other Properties (Quarterly) (USD)|Ikena Oncology Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0506|IKNA|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0506|IKNA|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0506|IKNA|5|91|91||91||91|91|91||91|91||1.44298245614|91.5|1.44298245614|91.5|1.44298245614||1.44||91|1.44298245614|91.5|15.3||91|91|92||||92|31|91.3333333333||91.3333333333|91.3333333333|22.3||91|91|91|91.3333333333|91.3333333333||92|91|91||91.3333333333||91.3333333333|91.3333333333||1.44298245614|1.44298245614|1.44298245614|1.44221105528||15.3|||1.44117647059|1.44117647059|91.4285714286|91.4285714286|91.5|91.5|91.5|91.5|27.4444444444|41.1666666667|30.875|16.4666666667|30.875|20.5833333333|22.4545454545|91.3333333333|91.3333333333||||91|91.5||
new_0222_0506|IKNA|6|3|3||3||3|3|3||3|3||228|2|228|2|228||225||3|228|2|20||3|3|1||||1|1|6||6|6|10||3|3|3|6|6||1|3|3||6||6|6||228|228|228|199||20|||34|34|7|7|2|2|2|2|9|6|8|15|8|12|11|6|6||||3|2||
new_0222_0506|IKNA|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0506|IKNA|202003||||||||||||||||||||||||||||||||||13.9876||-0.4965|2.51||||||-0.4965|||||||3.227||-6.945|-6.945|||||||||||||||||||||||||7.893|0.074|||||||
new_0222_0506|IKNA|202006||||||||||||||||||||||||||||||||||13.9876||-0.3602|1.798||||||-0.3602|||||||3.073||-5.038|-5.038|||||||||||||||||||||||||6.334|0.543|||||||
new_0222_0506|IKNA|202009||||||||||||||||||||||||||||||||||13.9876||-0.4448|1.844||||||-0.4448|||||||2.829||-6.222|-6.222|||||||||||||||||||||||||7.218|-0.392|||||||
new_0222_0506|IKNA|202012|165.969|162.491||1.563||269.452|28.332|241.12||-101.048|-111.339|||||||||||||||2.122|0.003|||||||34.588|33|-0.7532|2.716|||34.588||5.7352|-0.7532||||-44.256|9.194||0.065||-26.051|-26.051|||||||||||||||||||||||||23.402|0.075||||1.312|||
new_0222_0506|IKNA|202103|283.234|281.01||9.556||66.018|30.015|36.003||227.644|-121.055||77.5115|-15.561|-17.1741|2.4919|49.6816||4.449||||-13.0759|0.4427||2.528|0.036|||||||3.8503||-2.52|3.173|35.8512||35.8512||9.3623|-2.52|-132.432|||-47.027|9.441||3.474||-9.716|-9.716||28.25|28.25|731.7864|139931.3667||158719|||||-0.5|4.386|-404|-20.7934|-2.52|3.474|17.6055|30.6962|28.5|1.25|2|-1.88|-2.04|10.021|0.089||||8.929|0.384|24.47|18
new_0222_0506|IKNA|202106|268.71|264.004||9.245||62.567|30.543|32.024||216.26|-133.736||24.1462|-4.3801|-4.7128|0.8588|31.2453||2.328||||-26.0798|4.3688||2.474|0.036|-47.8364||||-47.8364|95.8036|35.8533||-0.35|4.862|35.8591||35.8591||8.6437|-0.35|1.13||-47.8364|-54.67|9.917||3.549||-12.681|-12.681||14.04|14.04|239.4578|122768.3||1566599|||||-0.4|3.9308|12.5|-9.7119|-0.35|3.549|16.5858|30.3343|27|1.25|2|-2.31|-2.03|11.374|0.713||||8.764|0.384|9.91|12.87
new_0222_0506|IKNA|202109|251.865|245.899||8.968||58.442|30.572|27.87||203.263|-148.251||19.0953|-3.2857|-3.3741|0.7905|32.0776||2.2275||||-28.9992|3.6498||1.928|0.036|-46.1167||||-46.1167||35.8603||-0.4|4.893|35.8778||35.8778||8.0433|-0.4|||-46.1167|-62.963|10.834||3.746||-14.515|-14.515||12.62|12.62|206.8788|85720.2667||1309462|||||-0.4233|4.0527|5.5111|-7.5689|-0.4|3.746|16.5858|29.1563|27|1.25|2|-3.14|-1.4|13.375|-0.421||||8.634|0.384|10.75|14.305
new_0222_0506|IKNA|202112|||||||||||||18.864||-3.3332||31.8743||2.2152|||||5.2513|||||||||||||||||||||||||||||||12.54|12.54|204.3723|212165.6||1885575|||16.9754|18.8728|-0.504|4.7858|||||15.5612|26.525|26.3333|1.4|3|-2.702|-1.886||||||||9.73|7.85
new_0222_0506|IKNA|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.4133|11.28||||||||||||||||||||
new_0222_0506|IKNA|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.45|11.355||||||||||||||||||||
new_0222_0506|IKNA|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.48|11.43||||||||||||||||||||
new_0222_0506|IKNA|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.5067|11.5055||||||||||||||||||||